Articles with "neuropsychiatric disease" as a keyword



The role of the lateral septum in neuropsychiatric disease

Sign Up to like & get
recommendations!
Published in 2022 at "Journal of Neuroscience Research"

DOI: 10.1002/jnr.25052

Abstract: The lateral septum (LS) is a structure in the midline of the brain that is interconnected with areas associated with stress and feeding. This review highlights the role of the LS in anxiety, depression, and… read more here.

Keywords: septum; septum neuropsychiatric; neuropsychiatric disease; role lateral ... See more keywords

Identifying dominant-negative actions of a dopamine transporter variant in patients with parkinsonism and neuropsychiatric disease

Sign Up to like & get
recommendations!
Published in 2021 at "JCI Insight"

DOI: 10.1172/jci.insight.151496

Abstract: Dysfunctional dopaminergic neurotransmission is central to movement disorders and mental diseases. The dopamine transporter (DAT) regulates extracellular dopamine levels, but the genetic and mechanistic link between DAT function and dopamine-related pathologies is not clear. Particularly,… read more here.

Keywords: dominant negative; k619n; dat; dopamine transporter ... See more keywords

Letter to the editor regarding the article “The use of Psychiatric Electroencephalography Evaluations Registry (PEER) to personalize pharmacotherapy”

Sign Up to like & get
recommendations!
Published in 2017 at "Neuropsychiatric Disease and Treatment"

DOI: 10.2147/ndt.s148087

Abstract: and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove… read more here.

Keywords: neuropsychiatric disease; regarding article; use; editor regarding ... See more keywords

Therapeutic deep brain stimulation worsening dysprosody in Parkinson’s disease – an unexplored entity

Sign Up to like & get
recommendations!
Published in 2018 at "Neuropsychiatric Disease and Treatment"

DOI: 10.2147/ndt.s160803

Abstract: and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove… read more here.

Keywords: neuropsychiatric disease; deep brain; disease; therapeutic deep ... See more keywords

Response to the paper titled “Identification of a novel CACNA1A mutation in a Chinese family with autosomal recessive progressive myoclonic epilepsy”

Sign Up to like & get
recommendations!
Published in 2018 at "Neuropsychiatric Disease and Treatment"

DOI: 10.2147/ndt.s179068

Abstract: and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove… read more here.

Keywords: neuropsychiatric disease; response paper; identification novel; titled identification ... See more keywords

Posterior pituitary neurohormonal disturbances in schizophrenia and role of oxytocin in treatment – need for more short- and long-term studies

Sign Up to like & get
recommendations!
Published in 2018 at "Neuropsychiatric Disease and Treatment"

DOI: 10.2147/ndt.s183645

Abstract: and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove… read more here.

Keywords: neuropsychiatric disease; treatment; posterior pituitary; neurohormonal disturbances ... See more keywords

Mild cognitive decline in type 2 diabetes mellitus patients – risk factors and pathogenesis: role of DPP4 activity and future possible therapeutic targets

Sign Up to like & get
recommendations!
Published in 2019 at "Neuropsychiatric Disease and Treatment"

DOI: 10.2147/ndt.s200663

Abstract: and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove… read more here.

Keywords: mild cognitive; decline type; type diabetes; neuropsychiatric disease ... See more keywords